Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

Federal Bank - One-off slippage mars performance - Centrum

Posted On: 2013-01-21 19:50:42

FED's Q3FY13 core performance was largely in line (PPP at Rs3.9bn vs Rs3.8bn estimated) though spike in provisions led to a lower than expected bottomline. NIM contracted by ~10bps QoQ on reversal of interest income on NPAs. Asset quality matrices deteriorated due to one-offs with 1) gross slippage rate jumping to 5.4% led by chunky slippage 2) GNPA going up 9% QoQ to 3.85% and 3) PCR eroding by 600bps QoQ despite high provisioning cost at 82bps. Notwithstanding the one-off hit to asset quality during the quarter, we remain positive on the radical changes introduced by the new management and its potential long term benefits. We stick to our thesis of RoE expansion, which in turn should drive further re-rating of the stock over the long term. We maintain Buy and target price of Rs600.

- NIM contracts by 11bps QoQ: NII de-grew by 6% YoY to Rs5.0bn as NIM contracted by 11bps QoQ offsetting the uptick in credit growth (19% YoY vs 8% last quarter). Importantly, the contraction in NIM was the result of reversal of interest income on NPAs (Rs300mn mainly Air India & NAFED). Meanwhile, cost of deposits inched up marginally as the last leg of NR deposits repriced upwards to post-deregulation rates. Q4FY13 would still have the burden of Air India FITL and hence will continue to contain NIMs. Management guided for a NIM of 3.55% for FY13.

- Uptick in loan growth: Loan growth during the quarter registered an uptick and stood at 19% YoY (from 8% in the previous quarter) with key segments driving growth. The corporate segment made a major comeback with 12.6% QoQ growth. Incrementally, the bank remains comfortable in expanding its SME and retail book given acceptable slippage performance though cautious stance towards corporate segment will stay for the near term. The management intends to close FY13 with a loan growth of 15-16% while for FY14 it expects to get more aggressive with target of ~25% YoY.

- Slippage rate spikes to 5.4%: After a clear moderating trend for the last 4 quarters, slippage rate spiked to 5.4% led by chunky NPAs. Exposure to NAFED (Rs2bn) was recognized as NPA (40% provided for) and the borrower has requested for a settlement with 40% haircut. Various banks exposed to NAFED have declined to accept 40% haircut and hence negotiations are underway with resolution likely in a couple of quarters. The bank sold off Rs710mn worth of NPAs to ARCIL, net of which the slippage rate would have been 4.8%. Effectively, the %GNPA inched up by 10bps QoQ to 3.85% while pushing the PCR down by 600bps QoQ to 77%.

- Maintain Buy: The management's strategy to enhance RoE by optimally leveraging the equity, enhancing liability franchisee and containing asset stress is gradually yielding results (albeit mixed). We expect the aggressive branch expansion to start yielding results over FY14 & FY15 in terms of growth and enhanced liability profile. At the current price, the stock is trading at 1.3x FY14E ABV and implies 19% upside to our price target of Rs600. We suggest investors should Buy the stock.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Views on Cadila Healthcare - USFDA update - Angel Broking
Views on Lupin - USFDA update - Angel Broking
Cement - Sector Update - Road trip & dealer checks - concrete movements - Centrum
HOLD : KPIT Technologies - Volatile performance plays spoilsport : AnandRathi Institutional Research
BUY KEC International - Growth levers in place: AnandRathi Institutional Research
BUY :Talwalkars Better-Value Fitness: AnandRathi Institutional Research
BUY Ceat - Latest strategy: agri-radial tyres for export: AnandRathi Institutional Research
HOLD Alembic Pharmaceutical: Minimal regulatory risk in the medium term - AnandRathi Institutional Research
Views on New FDI norms for Pharmaceuticals: Angel Broking
Views on Zydus Cadila- Acquires two ANDA's form Teva: Angel Broking
Mahanagar Gas Limited - IPO Note - Angel Broking
Views on update of Infosys: Angel Broking
Tech Mahindra - 4QFY2016 Result Update - Angel Broking
Views on Lupin Ltd 4QFY2016 Results: Angel Broking
Views on Ramco Cements Ltd 4QFY2016 Results: Angel Broking
Views on Punjab National Bank 4QFY2016 Results: Angel Broking
Dr Reddy's Laboratories - 4QFY2016 Result Update - Angel Broking
Cadila Healthcare - 4QFY2016 Result Update - Angel Broking
Visaka Industries Ltd - 4QFY2016 Result Update - Angel Broking
ITC - 4QFY2016 Result Update - Angel Broking
Lupin Ltd - 4QFY2016 Result Update - Angel Broking
Views on Tech Mahindra Ltd 4QFY2016 Results: Angel Broking
Voltas Ltd - 4QFY2016 Result Update - Angel Broking
Views on Cipla Ltd 4QFY2016 Results: Angel Broking
Views on GlaxoSmithKline Pharmaceuticals Limited 4QFY2016 Results: Angel Broking
HSIL - 4QFY2016 Result Update - Angel Broking
National Buildings Construction Corporation Ltd - 4QFY2016 Result Update - Angel Broking
Views on Indoco Remedies Ltd 4QFY2016 Results: Angel Broking
Views on State Bank of India 4QFY2016 Results: Angel Broking
Garware Wall Ropes - 4QFY2016 Result Update - Angel Broking
Larsen and Toubro - 4QFY2016 Result Update - Angel Broking
Views on IPCA Laboratories Ltd 4QFY2016 Results: Angel Broking
Views on Aurobindo Pharma Ltd 4QFY2016 Results: Angel Broking
Views on Sun Pharmaceutical Industries Limited 4QFY2016 Results: Angel Broking
Views on Voltas Limited 4QFY2016 Results: Angel Broking
Views on National Building Construction Corporation 4QFY2016 Results: Angel Broking
RSWM Limited - Q4FY16 Result Update - Anand Rathi
Views on IL&FS Transportation Networks Ltd 4QFY2016 Results: Angel Broking
Views on MM Forgings Ltd. 4QFY2016 Results - Angel Broking
Ujjivan listing - CapitalVia Global Research
Dewan Housing Finance - 4QFY2016 Result Update - Angel Broking
Procter & Gamble Hygiene & Health Care - 3QFY2016 Result Update - Angel Broking
Sanofi India - 1QCY2016 Result Update - Angel Broking
Views on HDFC Ltd. 4QFY2016 Results: Angel Broking
Views on Alembic Pharmaceuticals Ltd 4QFY2016 Results: Angel Broking
Rallis India - 4QFY2016 Result Update - Angel Broking
Views on United Phosphorous Ltd 4QFY2016 Results: Angel Broking
Views on Sanofi India Ltd 1QCY2016 Results: Angel Broking
Views on ICICI Bank 4QFY2016 Results: Angel Broking
Views on ACC Ltd. 1QCY2016 Results: Angel Broking


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2016